Anthem Inc. (ANTM) Lowered to Neutral at JPMorgan Chase & Co.
JPMorgan Chase & Co. lowered shares of Anthem Inc. (NYSE:ANTM) from an overweight rating to a neutral rating in a research note issued to investors on Monday. The firm currently has $132.00 price target on the stock, down from their previous price target of $154.00.
A number of other equities research analysts have also weighed in on the company. Leerink Swann reaffirmed a buy rating and set a $155.00 target price on shares of Anthem in a research report on Monday, September 26th. Evercore ISI assumed coverage on Anthem in a research report on Thursday, September 22nd. They set a hold rating and a $133.00 target price for the company. Zacks Investment Research raised Anthem from a sell rating to a hold rating in a research report on Tuesday, September 13th. Jefferies Group lowered Anthem from a buy rating to a hold rating and decreased their target price for the company from $156.00 to $138.00 in a research report on Tuesday, September 13th. Finally, FBR & Co reaffirmed a market perform rating and set a $155.00 target price on shares of Anthem in a research report on Monday, August 15th. Ten analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Anthem presently has a consensus rating of Hold and a consensus price target of $159.81.
Shares of Anthem (NYSE:ANTM) traded up 2.473% during trading on Monday, hitting $121.205. The company had a trading volume of 252,242 shares. The company has a market capitalization of $31.90 billion, a P/E ratio of 14.017 and a beta of 0.53. The stock’s 50-day moving average price is $124.50 and its 200 day moving average price is $132.09. Anthem has a 52 week low of $115.63 and a 52 week high of $149.50.
Anthem (NYSE:ANTM) last issued its earnings results on Wednesday, July 27th. The company reported $3.33 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.23 by $0.10. The business earned $21.27 billion during the quarter, compared to analyst estimates of $20.53 billion. Anthem had a return on equity of 12.16% and a net margin of 2.83%. Anthem’s revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the company posted $3.10 EPS. On average, equities research analysts forecast that Anthem will post $10.87 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Monday, September 26th. Shareholders of record on Friday, September 9th were paid a dividend of $0.65 per share. The ex-dividend date of this dividend was Wednesday, September 7th. This represents a $2.60 annualized dividend and a yield of 2.20%. Anthem’s payout ratio is presently 30.06%.
In other news, Director William J. Ryan sold 3,125 shares of the company’s stock in a transaction dated Thursday, July 28th. The stock was sold at an average price of $133.15, for a total value of $416,093.75. Following the sale, the director now owns 27,149 shares in the company, valued at $3,614,889.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Gloria M. Mccarthy sold 4,186 shares of the company’s stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $130.39, for a total value of $545,812.54. Following the completion of the sale, the executive vice president now owns 49,426 shares in the company, valued at approximately $6,444,656.14. The disclosure for this sale can be found here. Company insiders own 0.37% of the company’s stock.
Several hedge funds have recently modified their holdings of ANTM. Emerald Acquisition Ltd. bought a new stake in shares of Anthem during the second quarter worth approximately $242,981,000. Nordea Investment Management AB increased its stake in shares of Anthem by 34.4% in the second quarter. Nordea Investment Management AB now owns 6,420,978 shares of the company’s stock worth $843,331,000 after buying an additional 1,642,691 shares during the last quarter. Ameriprise Financial Inc. increased its stake in shares of Anthem by 793.1% in the second quarter. Ameriprise Financial Inc. now owns 1,642,830 shares of the company’s stock worth $215,768,000 after buying an additional 1,458,880 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of Anthem by 18.0% in the second quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 8,575,511 shares of the company’s stock worth $1,126,308,000 after buying an additional 1,306,670 shares during the last quarter. Finally, First Eagle Investment Management LLC increased its stake in shares of Anthem by 55.2% in the second quarter. First Eagle Investment Management LLC now owns 2,331,026 shares of the company’s stock worth $306,157,000 after buying an additional 829,542 shares during the last quarter. Hedge funds and other institutional investors own 89.45% of the company’s stock.
Anthem, Inc is a health benefit company. The Company offers a range of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. The Company has three segments: Commercial and Specialty Business, Government Business and Other. The Company’s Commercial and Specialty Business, and Government Business segments offer managed care products, including preferred provider organizations (PPOs), health maintenance organizations (HMOs), traditional indemnity benefits and point-of-service (POS) plans, as well as various hybrid benefit plans, including consumer-driven health plans (CDHPs), hospital only and limited benefit products.
Receive News & Stock Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related stocks with our FREE daily email newsletter.